other · Healthcare · Biotechnology
ONC
326.77+6.84 +2.14%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- ONC
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $33.19B
- Employees
- 12,000
- Currency
- USD
- Website
- https://beonemedicines.com
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow BeOne Medicines AG (ONC) across major market-data sources.